Corcept Therapeutics IncorporatedCORTNASDAQ
Loading
Year-over-year free cash flow growth rate
Percentile
P23
Within normal range
vs 5Y Ago
-1.8x
Contraction
Streak
2 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | -29.52% |
| Q3 2025 | 24.15% |
| Q2 2025 | 773.45% |
| Q1 2025 | -91.51% |
| Q4 2024 | -18.03% |
| Q3 2024 | 77.09% |
| Q2 2024 | 71.60% |
| Q1 2024 | 303.53% |
| Q4 2023 | -88.87% |
| Q3 2023 | 25.34% |
| Q2 2023 | 62.51% |
| Q1 2023 | -22.18% |
| Q4 2022 | 0.18% |
| Q3 2022 | 84.77% |
| Q2 2022 | -48.85% |
| Q1 2022 | -28.62% |
| Q4 2021 | 1.68% |
| Q3 2021 | 9.78% |
| Q2 2021 | 74.81% |
| Q1 2021 | -26.97% |
| Q4 2020 | 16.53% |
| Q3 2020 | -44.06% |
| Q2 2020 | 59.93% |
| Q1 2020 | -31.23% |
| Q4 2019 | 26.69% |
| Q3 2019 | 51.68% |
| Q2 2019 | 7.35% |
| Q1 2019 | 9.43% |
| Q4 2018 | -51.85% |
| Q3 2018 | 193.50% |
| Q2 2018 | -55.90% |
| Q1 2018 | 38.22% |
| Q4 2017 | 129.22% |
| Q3 2017 | -29.44% |
| Q2 2017 | 62.61% |
| Q1 2017 | 110.30% |
| Q4 2016 | -49.19% |
| Q3 2016 | 458.75% |
| Q2 2016 | -51.66% |
| Q1 2016 | -21.65% |